BRIDGEBIO ONCOLOGY THERAPEUT (BBOT) Institutional Ownership Changes & 13F Activity

BRIDGEBIO ONCOLOGY THERAPEUT (BBOT). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Vanguard Capital Management Llc, Opaleye Management Inc., Sphera Funds Management Ltd., Armistice Capital, Llc, and Granahan Investment Management, Llc.

InstitutionTypeChange in sharesChange Position %SharesReported stock balancePortfolio quarterFiling date
Manufacturers Life Insurance Company, TheSell-7,708-21.6%27,984$213.24KQ2 2026Sep 09, 2026
Citadel Advisors LlcBuy+89,065+3.5%2,617,827$19.95MQ2 2026Sep 02, 2026
Opaleye Management Inc.Buy+646,718+1213.8%700,000$5.33MQ2 2026Aug 14, 2026
Sphera Funds Management Ltd.Buy+460,985460,985$3.51MQ2 2026Aug 14, 2026
Armistice Capital, LlcBuy+436,000+32.8%1,764,000$13.44MQ2 2026Aug 14, 2026
Granahan Investment Management, LlcBuy+327,486+141.7%558,526$4.26MQ2 2026Aug 14, 2026
Catalio Capital Management, LpBuy+318,407318,407$2.43MQ2 2026Aug 14, 2026
Royce & Associates LpSell-251,581-39.5%384,941$2.93MQ2 2026Aug 14, 2026
Millennium Management LlcSell-160,474-60.3%105,480$803.76KQ2 2026Aug 14, 2026
Price T Rowe Associates IncSell-137,889-31.5%300,000$2.29MQ2 2026Aug 14, 2026
Bank Of America CorpBuy+77,14077,140$587.81KQ2 2026Aug 14, 2026
Brevan Howard Capital Management LpBuy+74,647+523.9%88,895$690.71KQ2 2026Aug 14, 2026
Goldman Sachs Group IncSell-65,488-39.1%102,085$777.89KQ2 2026Aug 14, 2026
Novo Holdings A/SBuy+64,077+2.9%2,250,000$17.14MQ2 2026Aug 14, 2026
Ensign Peak Advisors, IncSell-47,344-14.8%273,530$2.08MQ2 2026Aug 14, 2026
Wellington Management Group LlpSell-29,046-1.0%2,789,302$21.25MQ2 2026Aug 14, 2026
Two Sigma Investments, LpBuy+26,48526,485$201.82KQ2 2026Aug 14, 2026
Squarepoint Ops LlcSell-23,528-54.5%19,662$149.82KQ2 2026Aug 14, 2026
Rafferty Asset Management, LlcBuy+22,60622,606$172.26KQ2 2026Aug 14, 2026
Schonfeld Strategic Advisors LlcBuy+11,50411,504$87.66KQ2 2026Aug 14, 2026
Charles Schwab Investment Management IncSell-4,288-1.5%286,518$2.18MQ2 2026Aug 14, 2026
Mirae Asset Global Etfs Holdings Ltd.Buy+2,6262,626$20.11KQ2 2026Aug 14, 2026
Barclays PlcBuy+1,887+890.1%2,099$15.99KQ2 2026Aug 14, 2026
Quarry LpBuy+197197$1.50KQ2 2026Aug 14, 2026
Vanguard Capital Management LlcBuy+1,467,208+272.5%2,005,649$15.28MQ2 2026Aug 13, 2026
Bnp Paribas Financial MarketsBuy+100,333+110.5%191,152$1.46MQ2 2026Aug 13, 2026
Northern Trust CorpBuy+84,224+82.4%186,482$1.42MQ2 2026Aug 13, 2026
Laurion Capital Management LpBuy+80,045+4.2%2,002,701$15.26MQ2 2026Aug 13, 2026
Ubs Group AgBuy+64,205+127.3%114,655$873.67KQ2 2026Aug 13, 2026
Jump Financial, LlcBuy+62,00062,000$472.44KQ2 2026Aug 13, 2026
Showing 30 of 67

Frequently asked questions about BBOT activity

  • Which institutional owners are buying BBOT?

    Institutional owners buying BBOT include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in BBOT activity?

    "Buy" means an investor increased their reported position in BBOT compared to the prior reporting period. This reflects growing exposure to BRIDGEBIO ONCOLOGY THERAPEUT (BBOT) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in BBOT increasing?

    Institutional interest in BBOT can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.